Oncology Newswire (Page 8)

Oncology Newswire (Page 8)

Comprehensive Real-Time News Feed for Oncology. (Page 8)

Results 141 - 160 of 175,439 in Oncology

  1. Rihanna Named Harvard University's 2017 Humanitarian Of The YearRead the original story

    Thursday | SFGate

    ... arian Award during a ceremony on campus next week. "Rihanna has charitably built a state-of-the-art center for oncology and nuclear medicine to diagnose and treat breast cancer at the Queen Elizabeth Hospital in Bridgetown, Barbados," S. / Brandpoint

    Comment?

  2. Data on depression suggest possibility of personalized treatmentsRead the original story w/Photo

    Thursday | PhysOrg Weblog

    ... mortality among patients with lung cancer, according to a study published online Oct. 3 in the Journal of Clinical Oncology. How can you tell if someone is depressed? The Diagnostic and Statistical Manual of Mental Disorders (DSM) - the 'bible' of ...

    Comment?

  3. Novocure Announces Departure of Chief Commercial OfficerRead the original story

    Thursday | Customer Interaction Solutions

    ... Emerging Markets, and Shungo Matori, General Manager of Japan, will report directly to Mr. Danziger. Novocure is an oncology company developing a profoundly different cancer treatment centered on a proprietary therapy called TTFields, the use of ...

    Comment?

  4. Animal Specialty Center Introduces TrueBeama Radiotherapy System for Pet Cancer TreatmentRead the original story

    Thursday | Customer Interaction Solutions

    The ribbon cutting for the TrueBeam system was part of a continuing education seminar that included a presentation entitled, "Combining Surgery and Radiation" by ASC's Kendra Hearon, DVM, DACVS, Fellow in Surgical Oncology. "We are very excited to introduce this new technology to veterinary professionals because is it a real game-changer that will enable us to treat even the most challenging cases with unprecedented speed and pinpoint precision," said Kari Rosen, DVM, DACVR RO at ASC.

    Comment?

  5. Celgene Co. (CELG) Shares Sold by Wesbanco Bank Inc.Read the original story w/Photo

    Thursday | Daily Political

    ... of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Want to see what other hedge funds are holding CELG? Visit ...

    Comment?

  6. Rihanna named Harvard University's Humanitarian of the YearRead the original story w/Photo

    Thursday | WMGI-FM Terre Haute

    Rihanna is Harvard-bound -- not to study, but to pick up the University's Peter J. Gomes Humanitarian Award at a ceremony next Tuesday. S. Allen Counter , the Harvard Foundation's director, tells the Harvard Gazette , "Rihanna has charitably built a state-of-the-art center for oncology and nuclear medicine to diagnose and treat breast cancer at the Queen Elizabeth Hospital in Bridgetown, Barbados."

    Comment?

  7. Harvard names Rihanna its humanitarian of the yearRead the original story w/Photo

    Thursday | New Vision

    ... on campus on February 28, the university announced. "Rihanna has charitably built a state-of-the-art center for oncology and nuclear medicine to diagnose and treat breast cancer at the Queen Elizabeth Hospital in Bridgetown, Barbados," Harvard ...

    Comment?

  8. Influenza Diagnostics Market Worth 767.4 Million USD by 2021Read the original story w/Photo

    Thursday | PR Newswire

    ... advancements in this region. Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service ...

    Comment?

  9. Move Over Grammy Snub, Rihanna Is Harvard's Humanitarian Of The YearRead the original story w/Photo

    Thursday | She Knows

    ... into her work and why exactly she is being honored: "Rihanna has charitably built a state-of- the-art center for oncology and nuclear medicine to diagnose and treat breast cancer at the Queen Elizabeth Hospital in Bridgetown, Barbados." The ...

    Comment?

  10. Bristol-Myers Looms as Pharma's Next Megadeal as Activists JoinRead the original story w/Photo

    Thursday | Bloomberg

    ... it's lost ground to rivals like Merck & Co., which has a similar drug, Keytruda, that has taken the lead in some oncology markets. Bristol-Myers is still a tempting target. "If you believe in the immuno-oncology franchise, then it's obviously an ...

    Comment?

  11. New clinical practice guideline addresses testing of molecular...Read the original story w/Photo

    Thursday | Medical News

    A new, evidenced-based clinical practice guideline on molecular biomarker testing for patients with colorectal cancer identifies opportunities for improving patient outcomes. The American Society for Clinical Pathology , the College of American Pathologists , the Association for Molecular Pathology , and the American Society of Clinical Oncology collaborated to develop the Molecular Biomarkers for the Evaluation of Colorectal Cancer guideline.

    Comment?

  12. Zymeworks Submits ZW25 Phase 1 Clinical Study Findings Abstract for ASCO 2017Read the original story

    Thursday | Customer Interaction Solutions

    Zymeworks Inc. , a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer, today announced that it has submitted an abstract for the 2017 American Society of Clinical Oncology annual meeting that contains preliminary Phase 1 data from the ZW25 Phase 1 clinical trial for treatment of HER2-expressing tumors. "Two of the three cohorts from the dose escalation portion of the ZW25 Phase 1 clinical trial have been fully enrolled and preliminary data has been received for those patients," said Ali Tehrani, Ph.D., Zymeworks' President & CEO.

    Comment?

  13. New tool to measure patients' muscles could help predict chemotherapy side effectsRead the original story w/Photo

    Thursday | Medical News

    ... co-author Hyman B. Muss, MD, Mary Jones Hudson Distinguished Professor and director of the UNC Lineberger Geriatric Oncology Program. "It may be that muscle mass is related to the metabolism of chemotherapy in your body, as well as your general ...

    Comment?

  14. Novocure Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Company UpdateRead the original story w/Photo

    Thursday | Business Wire

    ... 31, 2016, highlighting year-over-year and sequential growth in active patients and net revenues. Novocure is an oncology company developing a profoundly different approach to cancer treatment centered on a proprietary therapy called TTFields, the ...

    Comment?

  15. Healthcare Research & Analytics Presents a Study on Defining...Read the original story w/Photo

    Thursday | PRWeb

    ... care from a patient's perspective. This work will help hospitals understand compassionate care perspectives from oncology patients and caregivers and help others in the fight to understand what is important for patients. This syndicated study ...

    Comment?

  16. Research: Biomaterials that mimic bone marrow can alter blood cell developmentRead the original story w/Photo

    Thursday | Medical News

    Researchers at the University of Illinois report they can alter blood cell development through the use of biomaterials designed to mimic characteristics of the bone marrow. The findings, reported in the journal Science Advances , are a first step toward developing more effective bone marrow treatments for diseases like leukemia and lymphoma.

    Comment?

  17. Ablynx Announces 2016 Full Year ResultsRead the original story

    Thursday | Information Technology

    ... as a result of a RSV infection initiation of the first clinical trial of a Nanobody developed as part of the immuno-oncology collaboration with Merck & Co., Inc. "We have made significant progress across a number of our key clinical programmes ...

    Comment?

  18. AJMC 's Evidence-Based Oncologya Publishes Third Annual Immuno-Oncology IssueRead the original story

    Thursday | PRWeb

    The advance of CAR-T technology and the rise of immuno-oncology alongside emerging new payment models highlight the annual review in Evidence-Based Oncologya , which looks at how researchers are harnessing the immune system to bring unprecedented results in cancer care. The idea of harnessing the power of the immune system as a means of bringing more effective, better-tolerated treatment solutions to patients in need is deeply inspiring.

    Comment?

  19. Adenovirus-mediated Foxp3 expression in lung epithelial cells...Read the original story

    Thursday | Gene Therapy

    Correspondence: J Cho, Department of Radiation Oncology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea E-mail: [email protected] ; Professor H Bae, Department of Physiology, College of Korean Medicine, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 02447, Republic of Korea. E-mail: [email protected] Received 25 April 2016; Revised 11 November 2016; Accepted 5 December 2016 Accepted article preview online 20 December 2016; Advance online publication 19 January 2017 Forkhead transcription factor 3 has a critical role in regulatory T cells .

    Comment?

  20. Novacyt: NOVAprep Regulatory Update in US and China Expands Commercial ReachRead the original story w/Photo

    Wednesday | Business Wire

    ... technology platform NovaPrepA and molecular platform, genesigA Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified ...

    Comment?